Leptin and insulin/IGF-1 are high in obese men (Hoda et al, 2010) and suppress androgen levels, moreover leptin has been implicated in advanced and high-grade prostate cancer in two case–control studies (Saglam et al, 2003; Ribeiro et al, 2006). This evidence concerns the gene LEP and prostate carcinoma.